Interface, Inc. (TILE) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary indicates strong financial performance, particularly in healthcare and corporate office billings. Despite a slight decline in education billings, the overall growth trends and strategic investments in automation and innovation are promising. The Q&A section reveals analysts' positive sentiment towards healthcare growth and automation benefits, although some concerns remain about margin details. The company's optimistic guidance and strategic focus on market expansion and product innovation suggest a positive outlook. Without market cap data, a precise prediction is challenging, but overall sentiment leans positive, likely resulting in a stock price increase of 2% to 8%.
Key Financial Performance
Net Sales $364.5 million, up 5.9% as reported and 4.2% on a currency-neutral basis versus the third quarter of 2024. Growth driven by strong execution and share gains.
Adjusted Gross Profit Margin 39.5%, up 208 basis points versus the third quarter of 2024. Increase driven by favorable pricing, product mix, and manufacturing efficiencies, partially offset by higher raw material and tariff-related costs.
Adjusted SG&A Expenses $90 million, compared to $85.5 million in the third quarter of 2024. Increase due to higher sales commissions, variable compensation, inflation, and foreign currency exchange variances.
Adjusted Operating Income $54.1 million, up 24.5% year-over-year. Growth attributed to increased sales and profitability.
Adjusted EBITDA $66.2 million, compared to $53.7 million in the third quarter of 2024. Growth driven by improved operational performance.
Adjusted Earnings Per Share $0.61, a 27% increase versus $0.48 in the third quarter of 2024. Increase due to higher profitability.
Operating Cash Flow $76.7 million generated during the third quarter. Reflects strong cash generation capabilities.
Net Debt $120.4 million, with a net leverage ratio of 0.6x. Indicates strong financial position and flexibility.
Currency-Neutral Orders Increased 2.4% year-over-year. Americas up 1.7%, EAAA up 3.5%. Growth driven by strength in EMEA and Australia.
Global Healthcare Billings Up 29% with double-digit gains across the Americas and EAAA. Growth driven by aging population, technological innovation, and focus on preventative care.
Corporate Office Billings Up 5% in the third quarter and year-to-date. Growth driven by share gains in Class A spaces and alignment with workplace trends.
Education Billings Declined slightly in the third quarter but remain up high single digits year-to-date. Decline attributed to timing-related factors.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Nora Rubber growth: Nora Rubber grew 20% in the third quarter and is up 19% year-to-date. A new rubber flooring innovation is planned for early 2026 to target the Healthcare segment.
New product launches: Introduced Horizon's carpet tile collection and three new resilient products, including two LVT styles and a refreshed norament XP rubber offering.
Healthcare segment growth: Global healthcare billings increased 29%, with double-digit gains in the Americas and EAAA, driven by aging populations and technological innovation.
Corporate office segment growth: Corporate office billings grew 5% in the third quarter, supported by demand for Class A spaces and hybrid workforce adaptations.
Education segment performance: Education billings declined slightly in Q3 but remain up high single digits year-to-date, with strong macro drivers and modernization initiatives.
Manufacturing efficiencies: Adjusted gross profit margin expanded by 208 basis points due to favorable mix and manufacturing efficiencies.
Automation and robotics: Investments in carpet tile automation and robotics improved efficiency, reduced waste, and enhanced service levels. These systems are being extended to Europe and Australia.
One Interface strategy: Unified sales team structure launched in January 2024, driving consistent growth and a cohesive customer experience across product categories.
Sustainability initiatives: Recognized for sustainability efforts, including being named Manufacturer of the Year in Ed's Net Zero Awards and aiming for carbon-negative operations by 2040.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Tariff-related costs: The company faces exposure to tariffs, particularly tied to imports of Nora Rubber from Germany and LVT from South Korea into the U.S. These tariffs have a dilutive impact on gross profit percentage, with a 30 basis point dilution in Q3 and an anticipated 50 basis point dilution in Q4.
Raw material costs: Higher raw material costs are partially offsetting gains from favorable pricing and product mix, impacting profitability.
Education segment performance: Education billings declined slightly in Q3, attributed to timing issues, though they remain up year-to-date. This decline could indicate potential challenges in maintaining consistent growth in this segment.
Economic uncertainties: The company operates in a challenging and uncertain macroeconomic environment, which could impact future performance and strategic execution.
Supply chain and automation investments: While investments in automation and robotics are delivering productivity gains, there is ongoing exploration for new opportunities, which could pose risks if these initiatives do not yield expected returns.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Future Product Launch: Preparing for the launch of a new rubber flooring innovation in early 2026 aimed at accelerating growth in the Healthcare segment and other areas.
Automation and Robotics Investments: Extending robotic systems to facilities in Europe and Australia, with ongoing exploration of new automation opportunities to improve productivity and margins.
Market Segment Growth Projections: Healthcare billings expected to grow due to aging population, technological innovation, and focus on preventative care. Corporate office billings are projected to benefit from companies moving to Class A spaces and adapting to hybrid workforce needs.
Revenue Guidance for FY 2025: Net sales projected to be between $1.375 billion and $1.390 billion.
Adjusted Gross Profit Margin: Anticipated to be 38.5% of net sales for FY 2025.
Capital Expenditures: Projected to be $45 million for FY 2025.
Tariff Impact Management: Plan to continue offsetting tariff-related costs through pricing and productivity initiatives, with an expected dilution of 50 basis points to Q4 adjusted gross profit percentage.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Share Repurchase: As part of our balanced capital allocation strategy, we repurchased $0.7 million of Interface common stock during the quarter.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What drove the sales outperformance relative to expectations three months ago?
A:Health care was the main driver, with a 29% increase in the quarter. The company has been focusing on expanding its product portfolio in health care and has seen strong performance from its One Interface selling teams, both in the U.S. and internationally.
Q:Can you provide more commentary on the investments in the Nora facility?
A:The company is investing in supporting capacity, productivity initiatives to increase throughput and drive efficiencies, and innovation. CapEx in 2026 may increase by around $10 million compared to 2025 levels to support these initiatives.
Q:How should we think about margins going forward, given the current guide of 38.5% for the year?
A:The company aims to achieve 38.5% margins this year, which requires a strong Q4. Management is balancing taking market share, serving customers, and maintaining a competitive position to achieve this target.
Q:How did Q3 momentum play out, and how is Q4 shaping up?
A:Q3 momentum was steady and consistent, with strong performance in the Americas. October continued the same trend. Outside the U.S., macroeconomic challenges, particularly in Europe, are being monitored, but Q4 guidance remains strong.
Q:Can you provide specific numbers for the education segment's performance?
A:The education segment declined by less than 3% (approximately 2.5%) in the quarter. However, it is up high single digits for the year, and Q2 is typically the peak season for education.
Q:What influenced gross margin expansion this quarter?
A:Gross margin expansion was driven by manufacturing efficiencies (about half of the gain), favorable price, and mix.
Q:Why was the tax rate unusually low at 4.8% this quarter?
A:The low tax rate was due to a noncash pickup of $10.4 million related to Germany's tax legislation changes, which required remeasurement of deferred tax assets and liabilities. The adjusted effective income tax rate for the year remains at 26%.
Q:What is the status of amortization of intangibles?
A:Amortization of intangibles has now run its course and will no longer appear on the P&L.
Q:What are the drivers for potential upside in gross margins beyond 38.5%?
A:Potential drivers include mix (e.g., U.S. and Nora Rubber sales growth), productivity initiatives, and volume leverage. Management is also focused on maintaining competitiveness and driving market share growth.
Q:What is the impact of automating the front end of manufacturing lines?
A:Automation has created productivity benefits, reduced waste, and improved inventory and cost of sales. These benefits are being extended to Europe and Australia, though the impact will be smaller than in the U.S.
Q:How should we think about incremental margins and their potential upside?
A:Management is focused on driving efficiencies, expanding addressable markets with accessible price points, and balancing mix and volume leverage. They plan to provide more clarity on future ambitions after year-end results.
Q:What is the progress on global product category management and its impact?
A:Global product category management has been implemented to drive innovation and expand the product portfolio. The company is focusing on selling a full suite of products to global customers, which is still in early stages.
Q:What is the breakdown of the $10 million increase in CapEx for next year?
A:A large portion of the increase is allocated to Nora, but there are also investments in innovation and automation outside of Nora.
Q:What is the approach to stock buybacks?
A:Stock buybacks are opportunistic, with the primary focus on investing in growth, margin expansion, and innovation. The company aims to return capital to shareholders when opportunities arise.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the potential upside in gross margins beyond 38.5%, stating they would provide more clarity after year-end results. Additionally, they did not quantify the exact impact of automation on gross margins or provide a detailed breakdown of incremental margins.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Americas momentum
Americas top
Australia backlog
Australia opportunity
Awards Planet
Awards award
Communications responsibility
EAAA product
EAAA region
EMEA Australia
Healthcare segment
Horizon carpet
Hurd CEO
Interface Conference
Interface Global
Interface expectation
Interface product
Interface ranking
Interface sale
Korea tariff
LVT approach
LVT style
Manufacturer Net
SGA
billing digit
company
date
design product
dollar
expectation currency
gain Americas
investment automation
manufacturing efficiency
margin basis
mix manufacturing
offering
percentage
point opportunity
product portfolio
service
share gain
TILE Transcript
Interface, Inc. (TILE) Q1 2026 Earnings Call Transcript
Unknown5-8
The earnings call reveals a mixed financial performance: revenue and income have increased, but gross margin has decreased due to higher costs. The company's EPS has grown, yet free cash flow has declined. No strategic updates or risk factors were discussed, and management responses were unclear. Without additional insights from the Q&A or strategic initiatives, the overall sentiment remains neutral, with no strong catalysts for significant stock movement in either direction.
Interface, Inc. (TILE) Q4 2025 Earnings Call Transcript
Positive2-24
The earnings call indicates strong financial performance with a significant increase in adjusted EPS and cash from operations. The company has shown growth across key segments like healthcare and education, and has a promising backlog. The Q&A session reveals confidence in managing costs and tariff impacts, with strategic investments in automation and product launches. Despite some vague responses, the overall sentiment is positive, with optimistic guidance and robust growth projections, likely leading to a positive stock price movement.
Interface, Inc. (TILE) Q3 2025 Earnings Call Transcript
Positive10-31
The earnings call summary indicates strong financial performance, particularly in healthcare and corporate office billings. Despite a slight decline in education billings, the overall growth trends and strategic investments in automation and innovation are promising. The Q&A section reveals analysts' positive sentiment towards healthcare growth and automation benefits, although some concerns remain about margin details. The company's optimistic guidance and strategic focus on market expansion and product innovation suggest a positive outlook. Without market cap data, a precise prediction is challenging, but overall sentiment leans positive, likely resulting in a stock price increase of 2% to 8%.
Interface, Inc. (TILE) Q2 2025 Earnings Call Transcript
Positive8-1
The earnings call summary and Q&A indicate strong financial performance, operational efficiency, and broad-based growth across markets. The company has exceeded sales guidance, improved margins, and maintains a strong balance sheet. While there are no new partnerships or significant shareholder return announcements, the optimistic guidance and sustainable market share gains suggest a positive outlook. The lack of detailed guidance on specific areas is a minor concern, but overall, the sentiment leans positive with an expected stock price increase of 2% to 8% over the next two weeks.
TILE Slides
TILE Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
